DrugPatentWatch Database Preview

Warner Chilcott Company Profile

WARNER CHILCOTT has eighty-four approved drugs.

There are five US patents protecting WARNER CHILCOTT drugs.

There are one hundred and twenty-one patent family members on WARNER CHILCOTT drugs in forty-four countries and fifty-six supplementary protection certificates in eleven countries.

International Patents:	121
US Patents:	5
Tradenames:	42
Ingredients:	39
NDAs:	84
Patent Litigation for Warner Chilcott:	See patent lawsuits for Warner Chilcott
PTAB Cases with Warner Chilcott as patent owner:	See PTAB cases with Warner Chilcott as patent owner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Warner Chilcott Llc	CHOLEDYL SA	oxtriphylline	TABLET, EXTENDED RELEASE;ORAL	087863-001	May 24, 1983		DISCN	No	No		➤ Sign Up				➤ Sign Up
Warner Chilcott	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	089529-001	May 3, 1988		DISCN	No	No		➤ Sign Up				➤ Sign Up
Warner Chilcott	LORAZEPAM	lorazepam	TABLET;ORAL	071038-001	Jan 12, 1988		DISCN	No	No		➤ Sign Up				➤ Sign Up
Warner Chilcott	LABID	theophylline	TABLET, EXTENDED RELEASE;ORAL	087225-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Warner Chilcott	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	087306-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,165,513*PED	➤ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	5,583,122*PED	➤ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	5,994,329*PED	➤ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,432,932*PED	➤ Sign Up
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,096,342*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	200 mg	➤ Subscribe	2013-08-12
➤ Subscribe	Delayed-release Tablets	80 mg	➤ Subscribe	2015-07-01
➤ Subscribe	Delayed-release Tablets	150 mg	➤ Subscribe	2008-12-19
➤ Subscribe	Delayed-release Tablets	200 mg	➤ Subscribe	2014-05-19
➤ Subscribe	Delayed-release Tablets	50 mg	➤ Subscribe	2015-11-05

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2008006,C0933372	Lithuania	➤ Sign Up	PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
C0025	Belgium	➤ Sign Up	PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
2016 00016	Denmark	➤ Sign Up	PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
00221	Netherlands	➤ Sign Up	PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
C/GB09/024	United Kingdom	➤ Sign Up	PRODUCT NAME: COMBINATION COMPRISING ALISKIREN, AS THE FREE BASE OR AS A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: CH 5893501 20081028; CH 5893502 20081028; CH 5893503 20081028; CH 5893504 20081028; UK EU/1/08/491/006 20090116; UK EU/1/08/491/002 20090116; UK EU/1/08/491/003 20090116; UK EU/1/08/491/004 20090116; UK EU/1/08/491/005 20090116; UK EU/1/08/491/007 20090116; UK EU/1/08/491/080 20090116; UK EU/1/08/491/074 20090116; UK EU/1/08/491/075 20090116; UK EU/1/08/491/076 20090116; UK EU/1/08/491/077 20090116; UK EU/1/08/491/078 20090116; UK EU/1/08/491/079 20090116; UK EU/1/08/491/068 20090116; UK EU/1/08/4
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.